Gastric cancer and brain metastasis: A systematic review and meta-analysis

被引:0
作者
Fotakopoulos, George [1 ]
Christodoulidis, Grigorios [2 ]
Georgakopoulou, Vasiliki Epameinondas [3 ]
Trakas, Nikolaos [4 ]
Skapani, Pagona [4 ]
Panagiotopoulos, Konstantinos [5 ]
Spandidos, Demetrios A. [6 ]
Foroglou, Nicolas [7 ]
机构
[1] Gen Univ Hosp Larisa, Dept Neurosurg, Mezourlo 1, Larisa 41221, Greece
[2] Gen Univ Hosp Larisa, Dept Gen Surg, Mezourlo 41221, Larisa, Greece
[3] Natl & Kapodistrian Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[4] Sismanogleio Hosp, Dept Biochem, Athens 15126, Greece
[5] Gen Hosp Athens Georgios Gennimatas, Biochem Lab, Athens 11527, Greece
[6] Univ Crete, Sch Med, Lab Clin Virol, Iraklion 71003, Greece
[7] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurosurg 1, Thessaloniki 54636, Greece
关键词
gastric cancer; brain metastasis; surgical resection; survival outcomes; conservative or no-surgical treatment;
D O I
10.3892/mco.2024.2775
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer (GC) constitutes one of the most wide-ranging cancers, with brain metastasis (BM) being a markedly uncommon and unfavorable outcome. The present meta-analysis evaluated the relationship between no-surgical treatment vs. additional surgical BM resection on the patient's quality of life and potential survival using electronic databases, including PubMed (1980-April 2024), Medline (1980-April 2024), Cochrane Library, and EMBASE (1980-April 2024). After a literature search, six articles were included in the final study pool. The number of patients with BM and conservative treatment was 289 (80.05%) compared with those that underwent an additional surgical resection 72 (19.95%). The mean age was 59.2 years, and the males were 195 (73.8%) of 264 available from five studies. The findings of the present meta-analysis revealed that the curative effect of BM tumor resection on patients with GC undergoing additional treatment with stereotactic radiosurgery, whole-brain radiotherapy or chemotherapy was favorable for their survival.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO
  • [2] 2-7
  • [3] Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews
    Amir-Behghadami, Mehrdad
    Janati, Ali
    [J]. EMERGENCY MEDICINE JOURNAL, 2020, 37 (06) : 387 - 387
  • [4] Bae JM, 2016, EPIDEMIOL HEALTH, V38
  • [5] Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data
    Davis, Faith G.
    Dolecek, Therese A.
    McCarthy, Bridget J.
    Villano, John L.
    [J]. NEURO-ONCOLOGY, 2012, 14 (09) : 1171 - 1177
  • [6] Investigation of the recurrence patterns of gastric cancer following a curative resection
    Deng, Jingyu
    Liang, Han
    Wang, Dianchang
    Sun, Dan
    Pan, Yi
    Liu, Yong
    [J]. SURGERY TODAY, 2011, 41 (02) : 210 - 215
  • [7] Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
    Fitzmaurice, Christina
    Abate, Degu
    Abbasi, Naghmeh
    Abbastabar, Hedayat
    Abd-Allah, Foad
    Abdel-Rahman, Omar
    Abdelalim, Ahmed
    Abdoli, Amir
    Abdollahpour, Ibrahim
    Abdulle, Abdishakur S. M.
    Abebe, Nebiyu Dereje
    Abraha, Haftom Niguse
    Abu-Raddad, Laith Jamal
    Abualhasan, Ahmed
    Adedeji, Isaac Akinkunmi
    Advani, Shailesh M.
    Afarideh, Mohsen
    Afshari, Mandi
    Aghaali, Mohammad
    Agius, Dominic
    Agrawal, Sutapa
    Ahmadi, Ayat
    Ahmadian, Elham
    Ahmadpour, Ehsan
    Ahmed, Muktar Beshir
    Akbari, Mohammad Esmaeil
    Akinyemiju, Tomi
    Al-Aly, Ziyad
    AlAbdulKader, Assim M.
    Alandab, Fares
    Alam, Tahiya
    Alamene, Genet Melak
    Alemnew, Birhan Tamene T.
    Alene, Kefyalew Addis
    Alinia, Cyrus
    Alipour, Vahid
    Aljunid, Syed Mohamed
    Bakeshei, Fatemeh Allah
    Abdulrahman, Majid
    Almadi, Hamad
    Almasi-Hashiani, Amir
    Alsharif, Ubai
    Alsowaidi, Shirina
    Alvis-Guzman, Nelson
    Amini, Erfan
    Amini, Saeed
    Amoako, Yaw Ampem
    Anbari, Zohreh
    Anber, Nahla Hamed
    Andrei, Catalina Liliana
    [J]. JAMA ONCOLOGY, 2019, 5 (12) : 1749 - 1768
  • [8] Reporting guidelines: CONSORT, PRISMA, and SQUIRE
    Foster, Roxie L.
    [J]. JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2012, 17 (01) : 1 - 2
  • [9] Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
    Gaspar, L
    Scott, C
    Rotman, M
    Asbell, S
    Phillips, T
    Wasserman, T
    McKenna, WG
    Byhardt, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04): : 745 - 751
  • [10] A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients A preliminary, three-center, clinical trial study
    Guo, Qinghong
    Li, Qiang
    Wang, Jiong
    Liu, Min
    Wang, Yuping
    Chen, Zhaofeng
    Ye, Yuwei
    Guan, Quanlin
    Zhou, Yongning
    [J]. MEDICINE, 2019, 98 (27)